scorecardresearch
Sunday, August 17, 2025
TopicRemdesivir

Topic: Remdesivir

Remdesivir, favipiravir sales zoom to record Rs 1,000 crore in 7 months in Covid year

Indian pharma industry launched 44 new antiviral brands in 2020, against just 10 such launches in 2019. However, total number of new brands saw 40% decline.

Scientists identify Covid drug that’s ‘27.5 times more potent than remdesivir’

A peer-reviewed study in Science journal concluded that the drug plitidepsin had "potent preclinical efficacy" against SARS-CoV-2.

Cipla to experiment with Covid drug remdesivir composition to reduce effect on kidneys

Government's subject expert committee asks Cipla to assess renal toxicity of remdesivir's new formulation through a bioequivalence study as well as clinical trials.

Vaccines are great news, but that doesn’t mean we can ignore therapeutics

Even if vaccines are as effective in the real world as they look in clinical trials, they can’t change the course of the pandemic overnight. We need reinforcements.

India will make Covid vaccine accessible to ‘closest friends’, Shringla says in Nepal

Shringla was speaking after handing over 2,000 vials of anti-virus drug Remdesivir to Nepal's Foreign Minister Pradeep Kumar Gyawali to help it contain the Covid pandemic.

WHO advice on remdesivir is a warning for Covid-19 vaccines

The WHO’s thumbs-down on remdesivir highlights why the FDA has to do more than merely rubber-stamp Covid-19 treatments in the face of heavy White House pressure to move quickly.

Delhi doctors unlikely to follow new WHO advice, say remdesivir works in moderate Covid cases

WHO Friday advised against use of remdesivir for Covid because there’s ‘no evidence’ it improves survival, but doctors say it works on moderately ill patients.

WHO advises against use of remdesivir to treat hospitalised Covid patients

WHO experts say their findings shouldn’t be interpreted to mean remdesivir is ineffective, but that there is no evidence it improves patient-important outcomes.

Remdesivir needs more testing in Covid Solidarity trial before being junked — ICMR-NARI chief

ICMR-NARI is body responsible for conducting WHO Solidarity trial in India, and its director Panda says remdesivir cannot be ruled out as a Covid treatment yet.

Final results of US trial reveal remdesivir could shorten recovery time in Covid patients

The results, published in NEJM, come weeks after WHO's Solidarity Trial concluded that remdesivir had little to no effect on hospitalised Covid patients.

On Camera

China wants to create new order in Myanmar. India must switch gears or be dealt out of the game

India’s policy on Myanmar has been to deal with its Generals and maintain a distance from the country’s insurgent groups and political struggles. This will have to change.

Modi’s ‘Diwali bonanza’ for the common man—next-gen GST reforms, lower tax on daily-use items soon

Finance ministry says the proposed revamp will focus on structural reforms, rate rationalisation & ease of living, & will be deliberated upon in the coming weeks.

What is Project Sudarshan Chakra, announced by Modi from ramparts of Red Fort

The project is meant to be a ‘protective shield that will keep expanding’, the PM said. It is on the lines of the ‘Golden Dome’ announced by Trump, it is learnt.

War of IAF, PAF doctrines: As Pakistan obsesses over numbers, India embraces risk, wins

Now that both IAF and PAF have made formal claims of having shot down the other’s aircraft in the 87-hour war in May, we can ask a larger question: do such numbers really matter?